GALLAI, Virgilio
 Distribuzione geografica
Continente #
EU - Europa 2.523
NA - Nord America 2.281
AS - Asia 435
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 5.247
Nazione #
US - Stati Uniti d'America 2.271
UA - Ucraina 691
SE - Svezia 670
IE - Irlanda 479
HK - Hong Kong 214
FI - Finlandia 147
IT - Italia 130
VN - Vietnam 128
DE - Germania 125
RU - Federazione Russa 102
GB - Regno Unito 99
CN - Cina 60
FR - Francia 23
CH - Svizzera 16
AT - Austria 10
TR - Turchia 10
CA - Canada 9
NL - Olanda 8
BE - Belgio 7
UZ - Uzbekistan 7
AU - Australia 5
PL - Polonia 5
SG - Singapore 5
CZ - Repubblica Ceca 4
GR - Grecia 4
LB - Libano 4
IR - Iran 2
BG - Bulgaria 1
BR - Brasile 1
EU - Europa 1
IN - India 1
JP - Giappone 1
KR - Corea 1
MX - Messico 1
NZ - Nuova Zelanda 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TW - Taiwan 1
Totale 5.247
Città #
Dublin 479
Chandler 442
Jacksonville 413
San Mateo 237
Hong Kong 214
Dong Ket 128
Medford 114
Princeton 114
Wilmington 105
Ashburn 81
Ann Arbor 73
Altamura 55
Andover 49
Lawrence 45
Woodbridge 37
Saint Petersburg 36
Helsinki 34
Beijing 28
Des Moines 27
Shanghai 27
Auburn Hills 20
Philadelphia 18
Norwalk 17
San Paolo di Civitate 14
Izmir 10
Los Angeles 10
Rome 10
Houston 8
Ottawa 8
Brussels 7
Den Haag 7
Bologna 6
Perugia 6
Barcellona Pozzo di Gotto 5
Boardman 5
Adelaide 4
Moscow 4
Redmond 4
Chicago 3
Frankfurt Am Main 3
New York 3
Catania 2
Milan 2
Salerno 2
Bay of Plenty 1
Bratislava 1
Chiang Mai 1
Collazzone 1
Dearborn 1
Edinburgh 1
Ferrara 1
Florence 1
Fremont 1
Groningen 1
Guelph 1
Kiev 1
Lausanne 1
Mariano Comense 1
Mexico City 1
Monzuno 1
Nanchang 1
Nanning 1
Naples 1
Napoli 1
New Delhi 1
Paris 1
Parma 1
Perth 1
Pitesti 1
Redwood City 1
San Diego 1
Seoul 1
Singapore 1
Spoltore 1
Taranto 1
Teresina 1
Terni 1
Tokyo 1
Totale 2.950
Nome #
A new assay for antiphospholipid antibodies in patient with ischemic stroke 102
Cerebrospinal fluid peptides, aminoacids and monoamine metabolites in lumbar puncture headache 95
Adhesion molecules and integrin expression by lymphocytes in the internal jugular blood of migraine patients during attacks. 84
a-D-Mannosidses in patients with familial Alzheimer's Disease 81
Brain SPECT in pathological aging brain: Alzheimer's disease, mild cognitive impairment and age-associated cognitive impairment. 81
a-D-Mannosidases in patients with Alzheimer's disease 80
Swalloving dysfunction: neurovascolar- anatomical correlation. 79
Trattamento sintomatico dell'emicrania giovanile.(Juvenile Migraine: Symptomatic Treatment) 77
Acetylcholinesterase and butyrylcholinesterase activity in cerebrospinal fluid of Alzheimer patients before and after 6-months treatment with donepezil. XXXI Congresso Società Italiana di Neurologia 74
Trattamento fibrinolitico nell’ictus acuto: una terapia costosa od un risparmio per la comunità? 71
Flow chart diagnostica nella cefalea giovanile 71
Excitotoxic effect of high frequency stimulation during hypoxia in hippocampal slices: neuroprotection by AP-5, a selective NMDA receptor antagonist 71
Variazioni di attività della paraoxonasi serica nella fase acuta dello stroke ischemico. Stroke'99 Meeting on Cerebrovascular Diseases 71
Normal pressure hydrocephalus and basilar artery aneurysm. Case report and pathogenic consideration 71
Disturbi dell'equilibrio nei pazienti con cefalea primaria: entità reale o soggettiva? Valutazione qualitativa e quantitativa mediante stabilometria statica - Atti XVI Conresso Nazionale "Cefalee ed età della vita" 70
Nitric oxide pathway, Ca and serotonin levels in platelets of patients affected by chronic daily headache: relationship with drug abuse 69
Studio della tensione muscolare mediante EMG-BFB e valutazione neuropsicologica 69
Outcome of Juvenile headache in outpatients attending 23 Italian Headache Clinics 68
La cefalea al risveglio. 68
NFKB and inducible Nitric oxide synthase mRNA and protein expression by monocytes from internal jugular blood of migraine without aura assesed during attacks. 68
Neurotransmitter abnormalities in cerebrospinal fluid of patients with lumbar puncture headache. 68
Brain SPECT in pathological aging brain: Alzheimer’s disease, mild cognitive impairment and age-associated cognitive impairment 66
Expression of d-mannosidase in amyotrophic lateral sclerosis and Alzheimer's disease 66
XIV Congresso Nazionale SISC: Le cefalee verso il terzo millennio. (Atti del) 65
Influence of dementia on antithrombotic therapy prescribed before stroke in patients with atrial fibrillation. 65
Brain SPECT in the diagnosis of degenerative dementia. 64
L-arginine/nitric oxide patway, serotonin and calcium levels in platelets of patients with chronic daily headache with and without analgesic abuse. 63
Emgraphical ischemic test and MG++ concentration in Juvenile headache 62
Linee guida: iter diagnostico della cefalea giovanile 62
Sindrome da sospensione di barbiturici in un paziente con cefalea cronica quotidiana. 62
Event related potentials in post-traumatic headache 62
Activity levels of a beta1,6 N-acetylglucosaminyltransferase in lymphomonocytes from multiple sclerosis patients 62
Iter diagnostico e flow chart della cefalea giovanile 61
Application of the 1988 International Headache Society diagnostic criteria in nine Italian headache centers using a computerized structured record 61
Headache characteristics in obstructive sleep apnea syndrome. 60
An open label pilot study on the efficacy and tolerability of levetiracetam in the prophylaxys of migraine 60
99mTc-HMPAO-SPECT nell'invecchiamento cerebrale fisiologico, nei deficit di memoria età correlati e nella malattia di Alzheimer: studio longitudinale a un anno. 58
Cerebrospinal fluid acetylcholinesterase activity after long-term treatment with donepezil and rivastigmina. 58
Relazione tra ossido nitrico e metabolismo prostaglandinico nell'attacco spontaneo di emicrania. 57
Electromyographical ischemic test, clinical symptoms related to neuromuscular hyperexcitability, and intra and extra cellular Mg levels in headache patients 57
Activation of complement and contact system in Alzheimer’s disease 56
99mTc-HMPAO-SPECT contribution in the differential diagnosis of cognitive dysfunction. 54
Emissione di idrocarburi volatili e stress ossidativo nelle apnee ostruttive nel sonno (SAOS). 52
Atrial fibrillation and stroke. 52
Cluster headache in childhood and adolescence: one year prevalence in an out-patient population. 51
Brain SPECT in different dementia disorders: AD, Possible AD, Preclinical AD, AAMI, FTD, LBD, VaD, secondary dementia. 51
Emissione di idrocarburi volatili e stress ossidativo nelle apnee ostruttive nel sonno (SAOS) 49
1H-MRS in patients with multiple sclerosis undergoing treatment with interferon beta-1a: results of a preliminary study 49
Nerve Growth factor in the cerebrospinal fluid of patients affected by chronic daily headache 48
Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors 46
Selection of thrombogenetic antiphospholipid antibodies in cerebrovascular disease patients. 46
Serum paraoxonase activity in early phases of acute ischemic stroke. VIII European Stroke Conference 46
Neuron Specific Enolase (NSE), beta-amyloid and tau proteins as markers of dementia. 45
Mild Hyperhomocyst(e)inemia: A possible Risk Factor for Cervical Artery Dissection 45
Phospholipid autoantibodies: time for a new immuno-assay? 44
Plasma total homocysteine levels and the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene : a study in an Italian population with dementia 44
Tranexamic acid, intrauterine contraceptive devices and fatal cerebral arterial thrombosis. Case report 44
Secondary prevention of stroke in patients with atrial fibrillation: factors influencing the prescription of oral anticoagulation at discharge. 42
CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies. Phospho-Tau International Study Group. 42
Brain CT scan in acute ischemic stroke: early signs and functional outcome. 41
Cefalee secondarie a lesioni espansive endocraniche. 41
Brain-derived neurotrophic factor in patients with multiple sclerosis. 40
Heart-brain relationship: atrial fibrillation and stroke. 39
Hyperhomocyst(e)inemia: a risk factor for cerebrovascular disease 39
Emicrania: eziopatogenesi clinica e terapia 39
Cytokine secretion and nitric oxide production by mononuclear cells of patients with multiple sclerosis 39
Glutamate and nitric oxide in chronic daily headache : mediators of central sensitization? 38
Cerebrospinal fluid biochemical markers in early detection and in differential diagnosis of dementia disorders in routine clinical practice. 38
Dysphagia following Stroke. 37
Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid. 37
Pharmacological treatment of non-cognitive disturbances in dementia disorders. 37
Funzionalità piastrinica e attività NO sintasica nella cefalea di tipo tensivo cronico 37
The Perugia hospital-based Stroke Registry: report of the 2nd year. 36
Vertebral artery dissection and hyperhomocysteinemia: a case report. 35
CSF Neuron Specific Enolase as a biological marker of Alzheimer's disease and subcortical vascular dementia. 34
Stroke prevention and atrial fibrillation: reasons leading to an inappropriate management. Main results of the SAFE II study. 34
Is ultrasound examination sufficient in the evaluation of patients with internal carotid artery severe stenosis or occlusion? 34
Corso Nazionale di Aggiornamento SISC (Abstract del) 34
Diagnosi differenziale tra cefalee primarie e secondarie di interesse neurologico 34
Prestroke dementia in patients with atrial fibrillation. Frequency and associated factors. 33
Expression of TNF-alpha mRNA by peripheral blood mononuclear cells of multiple sclerosis treated with IFN-beta 1A. 33
Cerebrospinal fluid pyruvate levels in Alzheimer’s Disease and vascular dementia 33
Relevance of protein nitration in brain injury: a key pathophysiological mechanism in neurodegenerative, autoimmune, or inflammatory CNS diseases and stroke 33
Magnetization transfer changes of grey and white matter in Parkinson’s disease 31
Radioligand binding assay of M1-M5 muscarinic cholinergic receptor subtypes in human peripheral blood lymphocytes 31
Role of neuroprotective drugs in acute ischemic stroke. 31
Levels of nerve growth factor in cerebrospinal fluid of chronic daily headache patients. 31
Brain CT-scan in acute stroke patients: silent infarcts and relation to outcome. 31
The inflammatory response in cerebral ischemia: focus on cytokines in stroke patients 30
Recanalization of cervical artery dissection: influencing factors and role in neurological outcome. 30
Disturbi del sonno nelle cefalee primarie. 30
Normal pressure hydrocephalus and basilar artery aneurysm 30
Platelet-activating factor (PAF) in internal jugular venous blood of migraine without aura patients assessed during migraine attacks. 29
Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical data. 29
Treatment of cognitive dysfunction associated with Alzheimer’s disease with colinergic precursors. Ineffective treatments or inappropriate approaches? 29
Event-related potentials in posttraumatic headache. 29
Stroke and atrial fibrillation: is stroke prevention treatment appropriate beforehand? SAFE I Study Investigators. 29
Clinical and genetic analysis of hereditary and sporadic ataxia in central Italy 28
Intracellular Mg++ concentration and Emgraphical ischemic test in Juvenile headache 28
Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's 27
Totale 5.043
Categoria #
all - tutte 18.238
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.238


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201932 0 0 0 0 0 0 0 0 0 0 32 0
2019/2020552 8 5 104 4 103 4 101 14 102 19 12 76
2020/20211.435 3 100 80 100 329 131 112 5 199 69 144 163
2021/2022934 36 205 57 104 25 0 9 266 4 7 100 121
2022/20231.478 118 173 21 111 136 172 4 64 629 1 36 13
2023/2024419 40 62 35 6 3 11 86 42 123 11 0 0
Totale 5.400